Researchers have developed a computational modeling platform that simulates tumor behavior and treatment response in liver ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...

Clinical data supporting the expanded approval come from the Phase I/II open-label multi-centre BUR-CL207 trial.

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary ...

No pain, no gain? Not any more ...

Kyowa Kirin EMEA, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151), today announced that the European Commission (EC) has approved an expansion of the indication for Crysvita® (burosumab) ...

Tract Bio ("Tract"), a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced presentations at the American Association for Cancer ...

Once I’m lying on the treatment bed, under a fluffy towel, there’s a double cleanse, using Dr David Jack’s own products - ...

Retinol, peptides, AHAs—all the skincare things. But my favorite, and arguably the most noticeable difference I’ve ever ...

Peer-reviewed preclinical findings validate the regenerative mechanism of HILO WAVE®'s proprietary Dual-HA Technology (DHC®).

There is a quiet shift happening in aesthetic medicine, and it has less to do with looking younger than with aging well. For ...